Point-of-Care Ultrasound in Greater Trochanteric Pain Syndrome
NCT ID: NCT01642043
Last Updated: 2022-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2012-06-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim of this study is to describe the soft tissue and bony structural ultrasound (US) findings identified in the lateral hip and iliotibial band (ITB) in patients presenting with greater trochanteric pain syndrome (GTPS) in an outpatient rheumatology clinic.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Experiences of Patients With Greater Trochanteric Pain Syndrome.
NCT03720587
Load Modification Versus Standard Exercise for Greater Trochanteric Pain Syndrome
NCT03571971
Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)
NCT04219098
Immediate Post-THA Functional Assessment
NCT04928924
Feasibility of Home Exercises With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain in General Practice
NCT05086926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Point-of-care musculoskeletal US use has been shown to reduce repeated hospital appointments, improve accuracy of diagnosis, and provide expedited treatment, thus improving quality of care in an outpatient musculoskeletal clinic. US assessment is not routinely included in the management of GTPS patients and ideal imaging modalities are not established.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a pain score of at least 2 out of 10 on an 11-point numeric rating scale
* Lateral hip pain for at least 1 week
* For participants with bilateral GTPS, the most symptomatic hip will be considered the study hip
* Have a telephone
Exclusion Criteria
* BMI \> 40
* Evidence of severe OA of the study hip by X-ray
* Avascular necrosis of the study hip
* Groin pain at rest or with log-rolling
* Hip internal rotation range of motion \< 15 degrees
* Prior fracture involving the study hip or femur
* Prior hip surgery or prosthesis in the painful hip
* Paralysis or paresis of the lower extremity
* Wheelchair bound
* Open wound or skin lesions in the lateral hip
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Minna Jean Kohler
Director, Musculoskeletal Ultrasound- Division of Rheumatology, Allergy, and Immunology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Minna J. Kohler, M.D.
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012p001126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.